Yuqing Tu

Jiangsu Key Laboratory Of Hematologic Diseases
Suzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Multicenter Analysis of Transplant Outcomes for the Newly Defined MDS/AML Entity in the 2022 ICC: Risk Stratification and Comparison with AML.

Multicenter Analysis of Transplant Outcomes for the Newly Defined MDS/AML Entity in the 2022 ICC: Risk Stratification and Comparison with AML.

Journal: Transplantation and cellular therapy

Published: January 23, 2026

Differential Prognosis and Transplant Strategies in CBF-AML With RUNX1::RUNX1T1 Versus CBFβ::MYH11 Fusions.

Differential Prognosis and Transplant Strategies in CBF-AML With RUNX1::RUNX1T1 Versus CBFβ::MYH11 Fusions.

Journal: American journal of hematology

Published: October 05, 2025

Drug screening reveals the mechanism of toyocamycin-induced apoptosis in triple-negative breast cancer organoids.

Drug screening reveals the mechanism of toyocamycin-induced apoptosis in triple-negative breast cancer organoids.

Journal: Toxicology and applied pharmacology

Published: August 26, 2025

Ruxolitinib as second-line therapy for bronchiolitis obliterans syndrome after hematopoietic cell transplantation: a retrospective multicenter study.

Ruxolitinib as second-line therapy for bronchiolitis obliterans syndrome after hematopoietic cell transplantation: a retrospective multicenter study.

Journal: Annals of hematology

Published: August 12, 2025

Haploidentical donor vs. human leukocyte antigen-matched donor hematopoietic cell transplantation for elderly patients with hematologic malignancies: Inferior non-relapse mortality but comparable survival.

Haploidentical donor vs. human leukocyte antigen-matched donor hematopoietic cell transplantation for elderly patients with hematologic malignancies: Inferior non-relapse mortality but comparable survival.

Journal: Chinese journal of cancer research = Chung-kuo yen cheng yen chiu

Published: July 22, 2025

CAR T-Cell therapy in chronic myeloid leukemia patients with lymphoid blast crisis: A multicenter clinical analysis.

CAR T-Cell therapy in chronic myeloid leukemia patients with lymphoid blast crisis: A multicenter clinical analysis.

Journal: Cancer letters

Published: February 05, 2025

Haploidentical-cord blood stem cell transplantation versus haploidentical stem cell transplantation for non-CR acute leukemia patients: a multicenter study.

Haploidentical-cord blood stem cell transplantation versus haploidentical stem cell transplantation for non-CR acute leukemia patients: a multicenter study.

Journal: Bone marrow transplantation

Published: April 07, 2024

Comparison of valganciclovir versus foscarnet for the treatment of cytomegalovirus viremia in adult acute leukemia patients after allogeneic hematopoietic cell transplantation.

Comparison of valganciclovir versus foscarnet for the treatment of cytomegalovirus viremia in adult acute leukemia patients after allogeneic hematopoietic cell transplantation.

Journal: Leukemia & lymphoma

Published: March 13, 2024

A model developed by machine learning and principal component analysis for predicting bronchiolitis obliterans syndrome after allogeneic HSCT in a Chinese population with hematologic malignancies.

A model developed by machine learning and principal component analysis for predicting bronchiolitis obliterans syndrome after allogeneic HSCT in a Chinese population with hematologic malignancies.

Journal: Computers in biology and medicine

Published: January 16, 2024

Clinical outcomes of patients with lymphoid blastic phase of chronic myeloid leukemia treated with CAR T-cell therapy.

Clinical outcomes of patients with lymphoid blastic phase of chronic myeloid leukemia treated with CAR T-cell therapy.

Journal: Blood cancer journal

Published: October 22, 2023

Current situation and development of hematopoietic cell transplantation centers: A nationwide survey in China.

Current situation and development of hematopoietic cell transplantation centers: A nationwide survey in China.

Journal: Chinese medical journal

Published: August 02, 2023

SETDB1 tumour suppressor roles in near-haploid mesothelioma involve TP53.

SETDB1 tumour suppressor roles in near-haploid mesothelioma involve TP53.

Journal: British journal of cancer

Published: July 25, 2022

Showing 1-12 of 16

Last Updated: 09/26/2026